News & Blog
News & Blog
Biogen Completes Acquisition of Reata Pharmaceuticals
Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
Initial Data from Phase 1 Multiple-Ascending Dose Trial of DT-216 for Friedreich Ataxia Showed Significant Increase in FXN mRNA Levels i...
2023 FARA Fellows
The FARA Fellow Program recognizes young investigators who will commit their early career to FA research and want to grow their profile ...